Sylvia K. Odesa

2.0k total citations
14 papers, 1.5k citations indexed

About

Sylvia K. Odesa is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Sylvia K. Odesa has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Oncology and 2 papers in Genetics. Recurrent topics in Sylvia K. Odesa's work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sylvia K. Odesa is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sylvia K. Odesa collaborates with scholars based in United States and Canada. Sylvia K. Odesa's co-authors include Linda M. Liau, Robert M. Prins, Thomas J. Kremen, Horacio Soto, William H. Yong, Timothy F. Cloughesy, Adrian J. Giovannone, Ascia Eskin, Seth Bouvier and Stanley F. Nelson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Neurology and Clinical Cancer Research.

In The Last Decade

Sylvia K. Odesa

14 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia K. Odesa United States 9 1.1k 766 488 305 202 14 1.5k
Samantha J. Busfield Australia 21 796 0.8× 625 0.8× 190 0.4× 578 1.9× 86 0.4× 41 1.9k
Steffen Aulwurm Germany 13 619 0.6× 478 0.6× 251 0.5× 599 2.0× 71 0.4× 16 1.3k
Ekaterina Friebel Switzerland 8 594 0.6× 358 0.5× 231 0.5× 272 0.9× 51 0.3× 11 987
Kevin Wei United States 5 850 0.8× 982 1.3× 233 0.5× 466 1.5× 52 0.3× 6 1.7k
Mara Kornete Canada 15 779 0.7× 341 0.4× 344 0.7× 308 1.0× 21 0.1× 19 1.3k
David Foulad United States 13 371 0.4× 481 0.6× 113 0.2× 414 1.4× 52 0.3× 17 1.0k
Ricardo Díez-Valle Spain 15 283 0.3× 432 0.6× 706 1.4× 333 1.1× 31 0.2× 27 1.2k
Petter Woll United Kingdom 21 755 0.7× 539 0.7× 317 0.6× 1.3k 4.2× 51 0.3× 48 2.2k
Chrystelle Lamagna United States 12 605 0.6× 270 0.4× 131 0.3× 439 1.4× 43 0.2× 18 1.2k
Jaya Goyal United States 15 211 0.2× 264 0.3× 275 0.6× 438 1.4× 200 1.0× 38 1.4k

Countries citing papers authored by Sylvia K. Odesa

Since Specialization
Citations

This map shows the geographic impact of Sylvia K. Odesa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia K. Odesa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia K. Odesa more than expected).

Fields of papers citing papers by Sylvia K. Odesa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia K. Odesa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia K. Odesa. The network helps show where Sylvia K. Odesa may publish in the future.

Co-authorship network of co-authors of Sylvia K. Odesa

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia K. Odesa. A scholar is included among the top collaborators of Sylvia K. Odesa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia K. Odesa. Sylvia K. Odesa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Antonios, Joseph, Richard G. Everson, Aaron Mochizuki, et al.. (2020). Abstract PR13: Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination. Cancer Immunology Research. 8(3_Supplement). PR13–PR13. 1 indexed citations
2.
Antonios, Joseph, Richard G. Everson, Horacio Soto, et al.. (2018). ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION. Neuro-Oncology. 20(suppl_6). vi10–vi10. 1 indexed citations
3.
Antonios, Joseph, Horacio Soto, Richard G. Everson, et al.. (2016). Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. Neuro-Oncology. 19(6). now287–now287. 151 indexed citations
4.
Moughon, Diana, Richard G. Everson, Sylvia K. Odesa, et al.. (2016). ATIM-32. PHASE IIA CLINICAL TRIAL EVALUATING DENDRITIC CELL VACCINE FOR THE TREATMENT OF LOW-GRADE GLIOMAS. Neuro-Oncology. 18(suppl_6). vi25–vi25. 1 indexed citations
5.
Prins, Robert M., Horacio Soto, Vera Konkankit, et al.. (2010). Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy. Clinical Cancer Research. 17(6). 1603–1615. 334 indexed citations
6.
Liau, Linda M., Robert M. Prins, Sylvia K. Odesa, et al.. (2007). Dendritic cell vaccination in combination with TLR-7 agonist, imiquimod, following radio-chemotherapy for newly diagnosed glioblastoma. Journal of Clinical Oncology. 25(18_suppl). 2021–2021. 3 indexed citations
7.
Liau, Linda M., Robert M. Prins, Sylvia M. Kiertscher, et al.. (2005). Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment. Clinical Cancer Research. 11(15). 5515–5525. 419 indexed citations
10.
Prins, Robert M., Sylvia K. Odesa, & Linda M. Liau. (2003). Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.. PubMed. 63(23). 8487–91. 97 indexed citations
11.
Kremen, Thomas J., et al.. (2003). MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor. Journal of Neuro-Oncology. 64(1-2). 21–30. 24 indexed citations
12.
Sicotte, Nancy L., Stephanie M. Liva, Seth Bouvier, et al.. (2002). Treatment of multiple sclerosis with the pregnancy hormone estriol. Annals of Neurology. 52(4). 421–428. 337 indexed citations
13.
Liau, Linda M., Eric R. Jensen, Thomas J. Kremen, et al.. (2002). Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.. PubMed. 62(8). 2287–93. 44 indexed citations
14.
Odesa, Sylvia K., et al.. (2000). Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor. Neurosurgical FOCUS. 9(6). 1–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026